Open access
Open access
Powered by Google Translator Translator

Editor's Choice

Perspective | The polypill: from concept and evidence to implementation.

18 Oct, 2022 | 12:55h | UTC

The polypill: from concept and evidence to implementation – The Lancet (free registration required)

News Release: The polypill could avoid millions of premature deaths, heart attacks and strokes every year, say leading cardiology experts – McMaster University

Related:

#ESCCongress | In patients within 6 months of a myocardial infarction, a polypill containing aspirin, ramipril, and atorvastatin resulted in a lower risk of major adverse cardiovascular events compared to usual care.

#ESCCongress – M-A: Polypills with and without aspirin substantially reduce cardiovascular disease, myocardial infarction, stroke, revascularization, and cardiovascular death in primary cardiovascular disease prevention.

Opinion: A new important study supports wider use of the polypill

#AHA20 – Randomized trial: A polypill comprising statins, multiple blood pressure lowering drugs, and aspirin prevents cardiovascular events among patients at intermediate cardiovascular risk

Perspective: Are Polypills and Population-based Treatment the Next Big Things?

The Polypill Revisited: Why We Still Need Population-Based Approaches in the Precision Medicine Era

Randomized Trial: Polypill for Cardiovascular Disease Prevention in an Underserved Population

Randomized Trial: Effectiveness of Polypill for Primary and Secondary Prevention of Cardiovascular Diseases

Clinical Impact of the Polypill for Cardiovascular Prevention in Latin America: A Consensus Statement of the Inter-American Society of Cardiology – Global Heart

Perspective: The Polypill and the Long Journey to Major Impact

Research: Low-Dose ‘Triple Pill’ Lowers Blood Pressure More Than Usual Care

 


Post-trial follow-up | Longer-term all-cause and cardiovascular mortality with intensive blood pressure control.

17 Oct, 2022 | 12:41h | UTC

Longer-Term All-Cause and Cardiovascular Mortality With Intensive Blood Pressure Control: A Secondary Analysis of a Randomized Clinical Trial – JAMA Cardiology (free for a limited period)

Author Interview: Longer-Term All-Cause and Cardiovascular Mortality With Intensive Blood Pressure Control – JAMA

Commentaries:

Benefits of Intensive Blood Pressure Control May Not Persist After Trial Intervention – HCP Live

Study Highlights Importance of Long-term Management of Hypertension – Wake Forest University School of Medicine

Related:

SPRINT Trial final report: targeting a systolic BP of less than 120 mm Hg in patients at increased CV risk is associated with improved CV and mortality outcomes but increases the risk of serious adverse events.

Study: Real-world blood pressure measurements vs. measurements taken in the SPRINT trial

Studies: Intensive versus Standard Blood-Pressure Control

 

Commentary on Twitter

 


Health effects associated with consumption of unprocessed red meat: a Burden of Proof study.

17 Oct, 2022 | 12:39h | UTC

Health effects associated with consumption of unprocessed red meat: a Burden of Proof study – Nature Medicine

See also:

News Release: New star rating system published in Nature Medicine helps people make informed decisions about diet and healthy habits – Institute for Health Metrics and Evaluation

Commentary: Expert reaction to studies presenting a standardized approach for quantifying the strength of evidence that supports associations between risk factors and health outcomes – Science Media Centre

Homepage: The Burden of Proof Studies – Nature Medicine

The Burden of Proof studies: assessing the evidence of risk

Health effects associated with vegetable consumption: a Burden of Proof study

Effects of elevated systolic blood pressure on ischemic heart disease: a Burden of Proof study

Health effects associated with smoking: a Burden of Proof study

 

Commentary on Twitter

 


Health effects associated with vegetable consumption: a Burden of Proof study.

17 Oct, 2022 | 12:40h | UTC

Health effects associated with vegetable consumption: a Burden of Proof study – Nature Medicine

See also:

News Release: New star rating system published in Nature Medicine helps people make informed decisions about diet and healthy habits – Institute for Health Metrics and Evaluation

Commentary: Expert reaction to studies presenting a standardized approach for quantifying the strength of evidence that supports associations between risk factors and health outcomes – Science Media Centre

Homepage: The Burden of Proof Studies – Nature Medicine

The Burden of Proof studies: assessing the evidence of risk

Health effects associated with consumption of unprocessed red meat: a Burden of Proof study

Effects of elevated systolic blood pressure on ischemic heart disease: a Burden of Proof study

Health effects associated with smoking: a Burden of Proof study

 

Commentary on Twitter

 


Effects of elevated systolic blood pressure on ischemic heart disease: a Burden of Proof study.

17 Oct, 2022 | 12:37h | UTC

Effects of elevated systolic blood pressure on ischemic heart disease: a Burden of Proof study – Nature Medicine

See also:

News Release: New star rating system published in Nature Medicine helps people make informed decisions about diet and healthy habits – Institute for Health Metrics and Evaluation

Commentary: Expert reaction to studies presenting a standardized approach for quantifying the strength of evidence that supports associations between risk factors and health outcomes – Science Media Centre

Homepage: The Burden of Proof Studies – Nature Medicine

The Burden of Proof studies: assessing the evidence of risk

Health effects associated with vegetable consumption: a Burden of Proof study

Health effects associated with consumption of unprocessed red meat: a Burden of Proof study

Health effects associated with smoking: a Burden of Proof study

 

Commentary on Twitter

 


Health effects associated with smoking: a Burden of Proof study.

17 Oct, 2022 | 12:36h | UTC

Health effects associated with smoking: a Burden of Proof study – Nature Medicine

See also:

News Release: New star rating system published in Nature Medicine helps people make informed decisions about diet and healthy habits – Institute for Health Metrics and Evaluation

Commentary: Expert reaction to studies presenting a standardized approach for quantifying the strength of evidence that supports associations between risk factors and health outcomes – Science Media Centre

Homepage: The Burden of Proof Studies – Nature Medicine

The Burden of Proof studies: assessing the evidence of risk

Health effects associated with vegetable consumption: a Burden of Proof study

Health effects associated with consumption of unprocessed red meat: a Burden of Proof study

Effects of elevated systolic blood pressure on ischemic heart disease: a Burden of Proof study

 

Commentary on Twitter

 


[Not published yet] Aspirin noninferior to LMW Heparin for prevention of death or pulmonary embolism after fracture surgery.

17 Oct, 2022 | 12:36h | UTC

Aspirin as effective as standard blood thinner to prevent life-threatening blood clots and death after fracture surgery – University of Maryland School of Medicine

 


RCTs | Thrombectomy improved recovery in basilar artery stroke but increased procedural complications and hemorrhages.

14 Oct, 2022 | 14:20h | UTC

Study 1: Trial of Endovascular Treatment of Acute Basilar-Artery Occlusion – New England Journal of Medicine (link to abstract – $ for full-text)

Study 2: Trial of Thrombectomy 6 to 24 Hours after Stroke Due to Basilar-Artery Occlusion – New England Journal of Medicine (link to abstract – $ for full-text)

Related:

Registry-based cohort study: Endovascular treatment vs. best medical management in acute basilar artery occlusion strokes.

RCT: Endovascular therapy for stroke due to basilar-artery occlusion – “endovascular therapy and medical therapy did not differ significantly with respect to a favorable functional outcome”.

 

Commentary on Twitter

 


Review | Facing the challenge of polypharmacy when prescribing for older people with cardiovascular disease.

14 Oct, 2022 | 14:19h | UTC

Facing the challenge of polypharmacy when prescribing for older people with cardiovascular disease. A review by the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy – European Heart Journal – Cardiovascular Pharmacotherapy

Related:

Deprescribing in Older Adults with Cardiovascular Disease – Journal of the American College of Cardiology

Multimorbidity in Older Adults with Cardiovascular Disease – American College of Cardiology, Latest in Cardiology

Deprescribing medicines in older people living with multimorbidity and polypharmacy: the TAILOR evidence synthesis – Health Technology Assessment

Antihypertensive Deprescribing in Older Adults: a Practical Guide – Current Hypertension Reports

How-to guide for medication reviews in older adults with cancer: A Young International Society of Geriatric Oncology and Nursing & Allied Health Interest Group initiative – Journal of Geriatric Oncology

Deprescribing in Palliative Cancer Care – Life

Less is More: Deprescribing Medications in Older Adults with Kidney Disease: A Review – Kidney360

Process evaluation of implementation strategies to reduce potentially inappropriate medication prescribing in older population: A scoping review – Research in Social and Administrative Pharmacy

AGA Clinical Practice Update on De-Prescribing of Proton Pump Inhibitors: Expert Review – Gastroenterology

Development of a Metric to Detect and Decrease Low-Value Prescribing in Older Adults – JAMA Network Open

The MedSafer Study—Electronic Decision Support for Deprescribing in Hospitalized Older Adults: A Cluster Randomized Clinical Trial – JAMA Internal Medicine

Quantifying Anticholinergic Burden and Sedative Load in Older Adults with Polypharmacy: A Systematic Review of Risk Scales and Models – Drugs & Aging

Deprescribing in palliative patients with cancer: a concise review of tools and guidelines – Supportive Care in Cancer

Prescribing practices, patterns, and potential harms in patients receiving palliative care: A systematic scoping review – Exploratory Research in Clinical and Social Pharmacy

A narrative review of evidence to guide deprescribing among older adults – Journal of General and Family Medicine

Polypharmacy, inappropriate prescribing, and deprescribing in older people: through a sex and gender lens – The Lancet Health Longevity

Polypharmacy Management in Older Patients – Mayo Clinic Proceedings

Psychopharmacological Treatment in Older People: Avoiding Drug Interactions and Polypharmacy – Deutsches Ärzteblatt international

Eliminating Medication Overload: A National Action Plan – Lown Institute

International Group for Reducing Inappropriate Medication Use & Polypharmacy (IGRIMUP): Position Statement and 10 Recommendations for Action – Drugs & Aging

Common ED Medication Errors: Polypharmacy – emDocs

Current and future perspectives on the management of polypharmacy – BMC Family Practice

Routine deprescribing of chronic medications to combat polypharmacy – Therapeutic Advances in Drug Safety

Polypharmacy—an Upward Trend with Unpredictable Effects – Deutsches Ärzteblatt international

Clinical Consequences of Polypharmacy in Elderly – Expert Opinion on Drug Safety

 


Special Statement | Postpartum visit checklists for normal pregnancy and complicated pregnancy.

14 Oct, 2022 | 14:18h | UTC

Society for Maternal-Fetal Medicine Special Statement: Postpartum visit checklists for normal pregnancy and complicated pregnancy – American Journal of Obstetrics & Gynecology

Original Guideline: ACOG Postpartum Toolkit (PDF)

 


2022 ACC Guidance on the evaluation and disposition of acute chest pain in the ED.

13 Oct, 2022 | 13:55h | UTC

2022 ACC Expert Consensus Decision Pathway on the Evaluation and Disposition of Acute Chest Pain in the Emergency Department: A Report of the American College of Cardiology Solution Set Oversight Committee – Journal of the American College of Cardiology

Commentary: Guideline Guidance: Practical Tips for Finding, Triaging Chest Pain in the ED – TCTMD

Related:

2021 AHA/ACC Guideline for the Evaluation and Diagnosis of Chest Pain.

High-sensitivity cardiac troponin and the 2021 AHA/ACC Guidelines for the evaluation and diagnosis of acute chest pain.

Navigating a Complicated World | Commentary of the new AHA/ACC Chest Pain Guidelines.

 

Commentary from one of the authors on Twitter (thread – click for more)

https://twitter.com/CianPMcCarthy/status/1580007497372676096

 


RCT | Allopurinol does not improve outcomes in patients with ischemic heart disease without previous gout.

13 Oct, 2022 | 13:53h | UTC

Allopurinol versus usual care in UK patients with ischaemic heart disease (ALL-HEART): a multicentre, prospective, randomised, open-label, blinded-endpoint trial – The Lancet

Invited Commentary: Xanthine oxidase inhibition for cardiovascular disease prevention – The Lancet

Related: [News release – not published yet] #ESCCongress – RCT | Allopurinol does not improve cardiovascular outcomes in ischemic heart disease patients.

 

Commentary on Twitter

Under a Creative Commons Attribution (CC BY 4.0) License

 


RCT | The substitution of biomass for gas cookstoves in pregnant women’s households did not improve infants’ birth weight.

13 Oct, 2022 | 13:52h | UTC

Liquefied Petroleum Gas or Biomass for Cooking and Effects on Birth Weight – New England Journal of Medicine (link to abstract – $ for full-text)

Commentaries:

LPG for cooking didn’t improve weight of newborns, finds study – The Times of India

Multi-country LPG trial shows drop in air pollution exposures, but insignificant impact on birth weight – Indian Express

 


Incidence of myocarditis/pericarditis following mRNA COVID-19 vaccination among children and younger adults in the US.

13 Oct, 2022 | 13:51h | UTC

Incidence of Myocarditis/Pericarditis Following mRNA COVID-19 Vaccination Among Children and Younger Adults in the United States – Annals of Internal Medicine

News Release: Incidence of myocarditis/pericarditis following mRNA COVID-19 vaccination among children, younger adults in the US – American College of Physicians

 

Commentary on Twitter (thread – click for more)

 

Commentary on Twitter

 


Case series and systematic review | Life-threatening cardiac arrhythmia and sudden death during electronic gaming.

13 Oct, 2022 | 13:49h | UTC

Life-threatening cardiac arrhythmia and sudden death during electronic gaming: An international case series and systematic review – Heart Rhythm

Editorial: Ventricular arrhythmias during electronic gaming: Sudden victory and sudden death – Heart Rhythm

News Release: Electronic gaming can trigger potentially lethal heart rhythm problems in susceptible children – Elsevier

 


Review | Transient ischemic attack and minor stroke: diagnosis, risk stratification and management.

13 Oct, 2022 | 13:50h | UTC

Transient ischemic attack and minor stroke: diagnosis, risk stratification and management – Canadian Medical Association Journal

 


15-year benefits of sigmoidoscopy screening on colorectal cancer incidence and mortality: a pooled analysis of randomized trials.

13 Oct, 2022 | 13:48h | UTC

15-Year Benefits of Sigmoidoscopy Screening on Colorectal Cancer Incidence and Mortality: A Pooled Analysis of Randomized Trials – Annals of Internal Medicine (link to abstract – $ for full-text)

News Release: One sigmoidoscopy significantly reduces long-term CRC incidence in both men and women – American College of Physicians

Related:

RCT | Effect of colonoscopy screening on risks of colorectal cancer and related death.

RCT: One-time flexible sigmoidoscopy screening is associated with long-term reduction in colorectal cancer incidence and mortality.

ACP Guideline: Screening for Colorectal Cancer in Asymptomatic Average-Risk Adults

BMJ Guideline: Colorectal Cancer Screening with Fecal Immunochemical Testing, Sigmoidoscopy or Colonoscopy

Current and future colorectal cancer screening strategies – Nature Reviews Gastroenterology & Hepatology (if the link is paywalled, try this one in PMC)

Consensus Statement: U.S. Multi-Society Task Force on Colorectal Cancer now suggests average-risk CRC screening begins at age 45.

USPSTF Statement: Start colorectal cancer screening at 45 years for most patients.

ACG Clinical Guidelines: Start colorectal cancer screening at 45

 

Commentary on Twitter

 


RCT | No difference in cardiovascular outcomes with evening vs. morning dosing of usual antihypertensives.

12 Oct, 2022 | 14:01h | UTC

Cardiovascular outcomes in adults with hypertension with evening versus morning dosing of usual antihypertensives in the UK (TIME study): a prospective, randomised, open-label, blinded-endpoint clinical trial – The Lancet

Related: [News release – not published yet] #ESCCongres – RCT | Evening dosing of blood pressure medication not better than morning dosing.

Related Consensus Statement: Bedtime dosing of antihypertensive medications: systematic review and consensus statement: International Society of Hypertension position paper endorsed by World Hypertension League and European Society of Hypertension – Journal of Hypertension

Related study (conflicting results): Bedtime Hypertension Treatment Improves Cardiovascular Risk Reduction in Randomized Trial

 


USPSTF Statement | Screening for anxiety is recommended in children and adolescents aged 8 to 18 years.

12 Oct, 2022 | 13:58h | UTC

Screening for Anxiety in Children and Adolescents: US Preventive Services Task Force Recommendation Statement – JAMA

Editorial: Screening for Pediatric Anxiety Disorders – JAMA

Evidence Report: Screening for Anxiety in Children and Adolescents: Evidence Report and Systematic Review for the US Preventive Services Task Force – JAMA

JAMA Patient Page: Screening for Anxiety in Children and Adolescents

Author interview: USPSTF Recommendations: Screening for Anxiety in Children and Adolescents, and Depression and Suicide Risk Screening in Children and Adolescents – JAMA

 


USPSTF Statement | Screening for depression and suicide risk is recommended in children and adolescents aged 12 to 18 years.

12 Oct, 2022 | 14:00h | UTC

Screening for Depression and Suicide Risk in Children and Adolescents: US Preventive Services Task Force Recommendation Statement – JAMA

Editorial: Screening for Adolescent Depression and Suicide Risk – JAMA

Evidence Report: Screening for Depression and Suicide Risk in Children and Adolescents: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force – JAMA

JAMA Patient Page: Screening for Depression and Suicide Risk in Children and Adolescents

Author Interview: USPSTF Recommendations: Screening for Anxiety in Children and Adolescents, and Depression and Suicide Risk Screening in Children and Adolescents – JAMA

 


RCT | Effect of colonoscopy screening on risks of colorectal cancer and related death.

11 Oct, 2022 | 13:42h | UTC

Effect of Colonoscopy Screening on Risks of Colorectal Cancer and Related Death – New England Journal of Medicine (link to abstract – $ for full-text)

Commentaries:

In gold-standard trial, invitation to colonoscopy reduced cancer incidence but not death – STAT

New study examines the effectiveness of colonoscopies – CNN

 


Review | Acid-base disorders in the critically ill patient.

11 Oct, 2022 | 13:41h | UTC

Acid-Base Disorders in the Critically Ill Patient – Clinical Journal of the American Society of Nephrology

 


Estimated global proportions of persistent fatigue, cognitive, and respiratory symptoms following symptomatic COVID-19.

11 Oct, 2022 | 13:39h | UTC

Estimated Global Proportions of Individuals With Persistent Fatigue, Cognitive, and Respiratory Symptom Clusters Following Symptomatic COVID-19 in 2020 and 2021 – JAMA

Commentaries:

Women And Hospitalized Patients More Prone To Long Covid, Study Finds – Forbes

Nearly two-thirds of long COVID patients are female, global study finds – UPI

 

Commentary on Twitter

 


Perspective | Hydrochlorothiazide vs. chlorthalidone – what is the difference?

11 Oct, 2022 | 13:40h | UTC

Hydrochlorothiazide Versus Chlorthalidone–What is the Difference? – Circulation (free for a limited period)

Related:

Meta-analysis: Chlorthalidone vs. hydrochlorothiazide

Large Observational Study Suggests Hydrochlorothiazide may be as Effective as Chlortalidone with Less Adverse Effects

 

Commentary on Twitter

 


Choosing Wisely | Top five list of procedures to avoid in the treatment of viral hepatitis.

7 Oct, 2022 | 14:22h | UTC

Choosing Wisely recommendations regarding the top five list of procedures to avoid in the treatment of viral hepatitis: a position statement from the Brazilian Society of Hepatology endorsed by the Latin American Association for the Study of the liver

See complete lists of low-value practices: Choosing Wisely U.S. / Choosing Wisely UK / Choosing Wisely Australia AND Choosing Wisely Canada

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.